Comments
Loading...
Pressure BioSciences Analyst Ratings and Price Targets | OTC:PBIO | Benzinga
Pressure BioSciences Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Pressure BioSciences Corp from these most-recent analyst ratings.
Analyst Ratings for Pressure BioSciences
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Pressure BioSciences (PBIO) stock?
There is no price target for Pressure BioSciences
What is the most recent analyst rating for Pressure BioSciences (PBIO)?
There is no analyst for Pressure BioSciences
When was the last upgrade for Pressure BioSciences (PBIO)?
There is no last upgrade for Pressure BioSciences
When was the last downgrade for Pressure BioSciences (PBIO)?
There is no last downgrade for Pressure BioSciences.
When is the next analyst rating going to be posted or updated for Pressure BioSciences (PBIO)?
There is no next analyst rating for Pressure BioSciences.
Is the Analyst Rating Pressure BioSciences (PBIO) correct?
There is no next analyst rating for Pressure BioSciences.
Browse analyst ratings and price targets on all stocks.
